In vitro and in vivo assays reveal 7-methoxyflavanone reduces inflammation and oxidative stress in acute lung injury, suggesting a potential therapeutic role.
Key Points
7-methoxyflavanone significantly reduced inflammatory markers in acute lung injury models, indicating its therapeutic potential.
In vivo tests confirmed that 7-methoxyflavanone alleviated lung injury by inhibiting TLR4 and NLRP3 signaling pathways.
The study employed in vitro LPS-induced assays in macrophages and in vivo tests in mice to evaluate the compound's effects.
These findings may inform future drug development strategies targeting acute lung injury mechanisms.